Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

Annals of Neurology

Volumn 78, Issue 5, 2015, Pages 801-813

  Saidha, Shiv ^a   Al Louzi, Omar ^a   Ratchford, John N ^a   Bhargava, Pavan ^a   Oh, Jiwon ^a   Newsome, Scott D ^a   Prince, Jerry L ^a,b   Pham, Dzung ^a,b,c   Roy, Snehashis ^a,b,c   Van Zijl, Peter ^a   Balcer, Laura J ^d   Frohman, Elliot M ^e   Reich, Daniel S ^a,f,g   Crainiceanu, Ciprian ^f   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; DISEASE COURSE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHENOTYPE; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; THALAMUS; WHITE MATTER; AGED; ATROPHY; BRAIN; LONGITUDINAL STUDY; MIDDLE AGED; OPTIC NEURITIS; PATHOLOGY; PROCEDURES; RETINA;

ADULT; AGED; ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; RETINA; RETINAL GANGLION CELLS; THALAMUS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84945120389     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24487     Document Type: Article

References (53)

1. Kappos L, Moeri D, Radue EW, et al., Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999; 353: 964-969.
2. Fisher E, Rudick RA, Simon JH, et al., Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59: 1412-1420.
3. Sormani MP, Arnold DL, De Stefano N., Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol 2014; 75: 43-49.
4. van Waesberghe JH, Kamphorst W, De Groot CJ, et al., Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-754.
5. De Stefano N, Narayanan S, Francis GS, et al., Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65-70.
6. Compston A, Coles A., Multiple sclerosis. Lancet 2002; 359: 1221-1231.
7. Miller DH., Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004; 1: 284-294.
8. Minneboo A, Uitdehaag BM, Jongen P, et al., Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Mult Scler 2009; 15: 632-637.
9. Calabrese M, Atzori M, Bernardi V, et al., Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212-1220.
10. Calabrese M, Agosta F, Rinaldi F, et al., Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144-1150.
11. Simon JH., Brain atrophy in multiple sclerosis: what we know and would like to know. Mult Scler 2006; 12: 679-687.
12. Inglese M, Oesingmann N, Casaccia P, Fleysher L., Progressive multiple sclerosis and gray matter pathology: an MRI perspective. Mt Sinai J Med 2011; 78: 258-267.
13. Saidha S, Syc SB, Ibrahim MA, et al., Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134 (pt 2): 518-533.
14. Petzold A, de Boer JF, Schippling S, et al., Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9: 921-932.
15. Frohman EM, Fujimoto JG, Frohman TC, et al., Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664-675.
16. Saidha S, Eckstein C, Ratchford JN., Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML-Multiple Sclerosis 2010; 2: 33-43.
17. Toussaint D, Perier O, Verstappen A, Bervoets S., Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3: 211-220.
18. Ikuta F, Zimmerman HM., Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology 1976; 26 (6 pt 2): 26-28.
19. Shindler KS, Ventura E, Dutt M, Rostami A., Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 2008; 87: 208-213.
20. Green AJ, McQuaid S, Hauser SL, et al., Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133: 1591-1601.
21. Kerrison JB, Flynn T, Green WR., Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445-451.
22. Ratchford JN, Saidha S, Sotirchos ES, et al., Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology 2013; 80: 47-54.
23. Talman LS, Bisker ER, Sackel DJ, et al., Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67: 749-760.
24. Gelfand JM, Nolan R, Schwartz DM, et al., Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 2012; 135 (pt 6): 1786-1793.
25. Saidha S, Sotirchos ES, Ibrahim MA, et al., Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012; 11: 963-972.
26. Gordon-Lipkin E, Chodkowski B, Reich DS, et al., Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603-1609.
27. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al., Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008; 268: 12-17.
28. Siger M, Dziegielewski K, Jasek L, et al., Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol 2008; 255: 1555-1560.
29. Dorr J, Wernecke KD, Bock M, et al., Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One 2011; 6: e18132.
30. Pfueller CF, Brandt AU, Schubert F, et al., Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One 2011; 6: e18019.
31. Young KL, Brandt AU, Petzold A, et al., Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol 2013; 20: 803-811.
32. Zimmermann H, Freing A, Kaufhold F, et al., Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 2013; 19: 443-450.
33. Saidha S, Sotirchos ES, Oh J, et al., Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013; 70: 34-43.
34. Polman CH, Reingold SC, Banwell B, et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
35. Lublin FD, Reingold SC., Defining the clinical course of multiple sclerosis: results of an international survey. national multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-911.
36. Bazin PL, Pham DL., Topology-preserving tissue classification of magnetic resonance brain images. IEEE Trans Med Imaging 2007; 26: 487-496.
37. Han X, Pham DL, Tosun D, et al., CRUISE: Cortical reconstruction using implicit surface evolution. Neuroimage 2004; 23: 997-1012.
38. Carass A, Cuzzocreo J, Wheeler MB, et al., Simple paradigm for extra-cerebral tissue removal: algorithm and analysis. Neuroimage 2011; 56: 1982-1992.
39. Shiee N, Bazin PL, Zackowski KM, et al., Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One 2012; 7: e37049.
40. Shiee N, Bazin PL, Ozturk A, et al., A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 2010; 49: 1524-1535.
41. Geremia E, Clatz O, Menze BH, et al., Spatial decision forests for MS lesion segmentation in multi-channel magnetic resonance images. Neuroimage 2011; 57: 378-390.
42. Warner CV, Syc SB, Stankiewicz AM, et al., The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 2011; 6: e22947.
43. Tewarie P, Balk L, Costello F, et al., The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One 2012; 7: e34823.
44. Syc SB, Saidha S, Newsome SD, et al., Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135 (pt 2): 521-533.
45. Saidha S, Syc SB, Durbin MK, et al., Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17: 1449-1463.
46. Syc SB, Warner CV, Hiremath GS, et al., Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 2010; 16: 829-839.
47. Costello F, Coupland S, Hodge W, et al., Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-969.
48. Reich DS, Smith SA, Gordon-Lipkin EM, et al., Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol 2009; 66: 998-1006.
49. Gabilondo I, Martinez-Lapiscina EH, Martinez-Heras E, et al., Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 2014; 75: 98-107.
50. Sotirchos ES, Saidha S, Byraiah G, et al., In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013; 80 (15): 1406-1414.
51. Kaufhold F, Zimmermann H, Schneider E, et al., Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One 2013; 8: e71145.
52. Barboni P, Carelli V, Savini G, et al., Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain 2013; 136 (pt 7): e239.
53. Wolff B, Basdekidou C, Vasseur V, et al., Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina 2013; 33: 2133-2138.